Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 39

    1.

    Adoptive cell therapy for lymphoma with CD4 T cells depleted of CD137-expressing regulatory T cells.

    Goldstein MJ, Kohrt HE, Houot R, Varghese B, Lin JT, Swanson E, Levy R.

    Cancer Res. 2012 Mar 1;72(5):1239-47. Epub 2012 Jan 9.

    PMID:
    22232735
    [PubMed - indexed for MEDLINE]
    2.

    IKKβ and NF-κB transcription govern lymphoma cell survival through AKT-induced plasma membrane trafficking of GLUT1.

    Sommermann TG, O'Neill K, Plas DR, Cahir-McFarland E.

    Cancer Res. 2011 Dec 1;71(23):7291-300. Epub 2011 Oct 10.

    PMID:
    21987722
    [PubMed - indexed for MEDLINE]
    3.

    Chromogranin A restricts drug penetration and limits the ability of NGR-TNF to enhance chemotherapeutic efficacy.

    Dondossola E, Gasparri AM, Colombo B, Sacchi A, Curnis F, Corti A.

    Cancer Res. 2011 Sep 1;71(17):5881-90. Epub 2011 Jul 28.

    PMID:
    21799030
    [PubMed - indexed for MEDLINE]
    4.

    Phase I study of PARP inhibitor ABT-888 in combination with topotecan in adults with refractory solid tumors and lymphomas.

    Kummar S, Chen A, Ji J, Zhang Y, Reid JM, Ames M, Jia L, Weil M, Speranza G, Murgo AJ, Kinders R, Wang L, Parchment RE, Carter J, Stotler H, Rubinstein L, Hollingshead M, Melillo G, Pommier Y, Bonner W, Tomaszewski JE, Doroshow JH.

    Cancer Res. 2011 Sep 1;71(17):5626-34. Epub 2011 Jul 27.

    PMID:
    21795476
    [PubMed - indexed for MEDLINE]
    5.

    Bcl-2 family genetic profiling reveals microenvironment-specific determinants of chemotherapeutic response.

    Pritchard JR, Gilbert LA, Meacham CE, Ricks JL, Jiang H, Lauffenburger DA, Hemann MT.

    Cancer Res. 2011 Sep 1;71(17):5850-8. Epub 2011 Jul 22.

    PMID:
    21784872
    [PubMed - indexed for MEDLINE]
    6.

    Chemotherapeutic resistance: surviving stressful situations.

    Gilbert LA, Hemann MT.

    Cancer Res. 2011 Aug 1;71(15):5062-6. Epub 2011 Jul 19.

    PMID:
    21771909
    [PubMed - indexed for MEDLINE]
    7.

    Akt-dependent glucose metabolism promotes Mcl-1 synthesis to maintain cell survival and resistance to Bcl-2 inhibition.

    Coloff JL, Macintyre AN, Nichols AG, Liu T, Gallo CA, Plas DR, Rathmell JC.

    Cancer Res. 2011 Aug 1;71(15):5204-13. Epub 2011 Jun 13.

    PMID:
    21670080
    [PubMed - indexed for MEDLINE]
    8.

    IGFBP-3 is a metastasis suppression gene in prostate cancer.

    Mehta HH, Gao Q, Galet C, Paharkova V, Wan J, Said J, Sohn JJ, Lawson G, Cohen P, Cobb LJ, Lee KW.

    Cancer Res. 2011 Aug 1;71(15):5154-63. Epub 2011 Jun 22.

    PMID:
    21697285
    [PubMed - indexed for MEDLINE]
    9.

    Prediagnostic serum levels of cytokines and other immune markers and risk of non-hodgkin lymphoma.

    Purdue MP, Lan Q, Bagni R, Hocking WG, Baris D, Reding DJ, Rothman N.

    Cancer Res. 2011 Jul 15;71(14):4898-907. Epub 2011 Jun 1.

    PMID:
    21632552
    [PubMed - indexed for MEDLINE]
    10.

    Epigenetic silencing of microRNA-203 dysregulates ABL1 expression and drives Helicobacter-associated gastric lymphomagenesis.

    Craig VJ, Cogliatti SB, Rehrauer H, Wündisch T, Müller A.

    Cancer Res. 2011 May 15;71(10):3616-24. Epub 2011 Mar 31.

    PMID:
    21454413
    [PubMed - indexed for MEDLINE]
    Free Article
    11.

    A simple approach to cancer therapy afforded by multivalent pseudopeptides that target cell-surface nucleoproteins.

    Destouches D, Page N, Hamma-Kourbali Y, Machi V, Chaloin O, Frechault S, Birmpas C, Katsoris P, Beyrath J, Albanese P, Maurer M, Carpentier G, Strub JM, Van Dorsselaer A, Muller S, Bagnard D, Briand JP, Courty J.

    Cancer Res. 2011 May 1;71(9):3296-305. Epub 2011 Mar 17.

    PMID:
    21415166
    [PubMed - indexed for MEDLINE]
    Free Article
    12.

    STAT3 inhibition is a therapeutic strategy for ABC-like diffuse large B-cell lymphoma.

    Scuto A, Kujawski M, Kowolik C, Krymskaya L, Wang L, Weiss LM, Digiusto D, Yu H, Forman S, Jove R.

    Cancer Res. 2011 May 1;71(9):3182-8. Epub 2011 Apr 26.

    PMID:
    21521803
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    13.

    Combining histone deacetylase inhibitor vorinostat with aurora kinase inhibitors enhances lymphoma cell killing with repression of c-Myc, hTERT, and microRNA levels.

    Kretzner L, Scuto A, Dino PM, Kowolik CM, Wu J, Ventura P, Jove R, Forman SJ, Yen Y, Kirschbaum MH.

    Cancer Res. 2011 Jun 1;71(11):3912-20. Epub 2011 Apr 18.

    PMID:
    21502403
    [PubMed - indexed for MEDLINE]
    Free Article
    14.

    Cytoplasmic CUL9/PARC ubiquitin ligase is a tumor suppressor and promotes p53-dependent apoptosis.

    Pei XH, Bai F, Li Z, Smith MD, Whitewolf G, Jin R, Xiong Y.

    Cancer Res. 2011 Apr 15;71(8):2969-77. Epub 2011 Apr 12.

    PMID:
    21487039
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    15.

    In vivo inhibition of human CD19-targeted effector T cells by natural T regulatory cells in a xenotransplant murine model of B cell malignancy.

    Lee JC, Hayman E, Pegram HJ, Santos E, Heller G, Sadelain M, Brentjens R.

    Cancer Res. 2011 Apr 15;71(8):2871-81. Epub 2011 Apr 12.

    PMID:
    21487038
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    16.

    CD73-deficient mice have increased antitumor immunity and are resistant to experimental metastasis.

    Stagg J, Divisekera U, Duret H, Sparwasser T, Teng MW, Darcy PK, Smyth MJ.

    Cancer Res. 2011 Apr 15;71(8):2892-900. Epub 2011 Feb 3.

    PMID:
    21292811
    [PubMed - indexed for MEDLINE]
    Free Article
    17.

    Protein kinase C inhibitor sotrastaurin selectively inhibits the growth of CD79 mutant diffuse large B-cell lymphomas.

    Naylor TL, Tang H, Ratsch BA, Enns A, Loo A, Chen L, Lenz P, Waters NJ, Schuler W, Dörken B, Yao YM, Warmuth M, Lenz G, Stegmeier F.

    Cancer Res. 2011 Apr 1;71(7):2643-53. Epub 2011 Feb 15.

    PMID:
    21324920
    [PubMed - indexed for MEDLINE]
    Free Article
    18.

    CCL11-CCR3 interactions promote survival of anaplastic large cell lymphoma cells via ERK1/2 activation.

    Miyagaki T, Sugaya M, Murakami T, Asano Y, Tada Y, Kadono T, Okochi H, Tamaki K, Sato S.

    Cancer Res. 2011 Mar 15;71(6):2056-65.

    PMID:
    21406396
    [PubMed - indexed for MEDLINE]
    Free Article
    19.

    Hippo/Mst1 stimulates transcription of the proapoptotic mediator NOXA in a FoxO1-dependent manner.

    Valis K, Prochazka L, Boura E, Chladova J, Obsil T, Rohlena J, Truksa J, Dong LF, Ralph SJ, Neuzil J.

    Cancer Res. 2011 Feb 1;71(3):946-54. Epub 2011 Jan 18.

    PMID:
    21245099
    [PubMed - indexed for MEDLINE]
    Free Article
    20.

    Cyclophosphamide synergizes with type I interferons through systemic dendritic cell reactivation and induction of immunogenic tumor apoptosis.

    Schiavoni G, Sistigu A, Valentini M, Mattei F, Sestili P, Spadaro F, Sanchez M, Lorenzi S, D'Urso MT, Belardelli F, Gabriele L, Proietti E, Bracci L.

    Cancer Res. 2011 Feb 1;71(3):768-78. Epub 2010 Dec 13.

    PMID:
    21156650
    [PubMed - indexed for MEDLINE]
    Free Article

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk